{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:49:05Z","timestamp":1792187345589,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1038\/s41401-019-0270-4","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T07:10:04Z","timestamp":1563347404000},"page":"249-259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["LW-213, a newly synthesized flavonoid, induces G2\/M phase arrest and apoptosis in chronic myeloid leukemia"],"prefix":"10.1038","volume":"41","author":[{"given":"Xiao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-xuan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-jie","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhan-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-zheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-yuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-long","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"key":"270_CR1","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/S0140-6736(13)62120-0","volume":"385","author":"JF Apperley","year":"2015","unstructured":"Apperley JF. Chronic myeloid leukaemia. Lancet. 2015;385:1447\u201359.","journal-title":"Lancet"},{"key":"270_CR2","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","volume":"105","author":"KJ Aichberger","year":"2005","unstructured":"Aichberger KJ, Mayerhofer M, Krauth MT, Skvara H, Florian S, Sonneck K, et al. Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides. Blood. 2005;105:3303\u201311.","journal-title":"Blood"},{"key":"270_CR3","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1182\/blood-2016-09-696013","volume":"129","author":"TL Holyoake","year":"2017","unstructured":"Holyoake TL, Vetrie D. The chronic myeloid leukemia stem cell: stemming the tide of persistence. Blood. 2017;129:1595\u2013606.","journal-title":"Blood"},{"key":"270_CR4","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2141.2006.06161.x","volume":"134","author":"P Coppo","year":"2006","unstructured":"Coppo P, Flamant S, De Mas V, Jarrier P, Guillier M, Bonnet ML, et al. BCR-ABL activates STAT3 via JAK and MEK pathways in human cells. Br J Haematol. 2006;134:171\u20139.","journal-title":"Br J Haematol"},{"key":"270_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2011.66","volume":"2","author":"G Polier","year":"2011","unstructured":"Polier G, Ding J, Konkimalla BV, Eick D, Ribeiro N, Kohler R, et al. Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis. 2011;2:e182.","journal-title":"Cell Death Dis"},{"key":"270_CR6","doi-asserted-by":"publisher","first-page":"e29736","DOI":"10.7554\/eLife.29736","volume":"6","author":"S Gressel","year":"2017","unstructured":"Gressel S, Schwalb B, Decker TM, Qin W, Leonhardt H, Eick D, et al. CDK9-dependent RNA polymerase II pausing controls transcription initiation. Elife. 2017;6:e29736.","journal-title":"Elife"},{"key":"270_CR7","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1182\/blood-2012-08-447441","volume":"122","author":"D Thomas","year":"2013","unstructured":"Thomas D, Powell JA, Vergez F, Segal DH, Nguyen NY, Baker A, et al. Targeting acute myeloid leukemia by dual inhibition of PI3K signaling and Cdk9-mediated Mcl-1 transcription. Blood. 2013;122:738\u201348.","journal-title":"Blood"},{"key":"270_CR8","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s00018-008-8637-6","volume":"66","author":"C Akgul","year":"2009","unstructured":"Akgul C. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci. 2009;66:1326\u201336.","journal-title":"Cell Mol Life Sci"},{"key":"270_CR9","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1158\/1078-0432.CCR-06-2294","volume":"13","author":"SRA Hussain","year":"2007","unstructured":"Hussain SRA, Cheney CM, Johnson AJ, Lin TS, Grever MR, Caligiuri MA, et al. Mcl-1 is a relevant therapeutic target in acute and chronic lymphoid malignancies: down-regulation enhances rituximab-mediated apoptosis and complement-dependent cytotoxicity. Clin Cancer Res. 2007;13:2144\u201350.","journal-title":"Clin Cancer Res"},{"key":"270_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/mc.22321","volume":"55","author":"L Zhao","year":"2016","unstructured":"Zhao L, Miao HC, Li WJ, Sun Y, Huang SL, Li ZY, et al. LW-213 induces G2\/M cell cycle arrest through AKT\/GSK3beta\/beta-catenin signaling pathway in human breast cancer cells. Mol Carcinog. 2016;55:778\u201392.","journal-title":"Mol Carcinog"},{"key":"270_CR11","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood-2012-11-466219","volume":"121","author":"Y Chen","year":"2013","unstructured":"Chen Y, Hui H, Yang H, Zhao K, Qin Y, Gu C, et al. Wogonoside induces cell cycle arrest and differentiation by affecting expression and subcellular localization of PLSCR1 in AML cells. Blood. 2013;121:3682\u201391.","journal-title":"Blood"},{"key":"270_CR12","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/leu.2013.369","volume":"28","author":"A Lonetti","year":"2014","unstructured":"Lonetti A, Antunes IL, Chiarini F, Orsini E, Buontempo F, Ricci F, et al. Activity of the pan-class I phosphoinositide 3-kinase inhibitor NVP-BKM120 in T-cell acute lymphoblastic leukemia. Leukemia. 2014;28:1196\u2013206.","journal-title":"Leukemia"},{"key":"270_CR13","doi-asserted-by":"publisher","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"270_CR14","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-981-13-1435-3_10","volume":"1088","author":"R Khalil","year":"2018","unstructured":"Khalil R. Ubiquitin-Proteasome Pathway and Muscle Atrophy. Adv Exp Med Biol. 2018;1088:235\u201348.","journal-title":"Adv Exp Med Biol"},{"key":"270_CR15","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1158\/1078-0432.CCR-15-0114","volume":"22","author":"CP Hall","year":"2016","unstructured":"Hall CP, Reynolds CP, Kang MH. Modulation of glucocorticoid resistance in pediatric T-cell acute lymphoblastic leukemia by increasing BIM expression with the PI3K\/mTOR inhibitor BEZ235. Clin Cancer Res. 2016;22:621\u201332.","journal-title":"Clin Cancer Res"},{"key":"270_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.critrevonc.2014.11.001","volume":"93","author":"K Yang","year":"2015","unstructured":"Yang K, Fu LW. Mechanisms of resistance to BCR-ABL TKIs and the therapeutic strategies: a review. Crit Rev Oncol Hematol. 2015;93:277\u201392.","journal-title":"Crit Rev Oncol Hematol"},{"key":"270_CR17","doi-asserted-by":"crossref","unstructured":"Zeijlemaker W, Grob T, Meijer R, Hanekamp D, Kelder A, Carbaat-Ham JC, et al. CD34(+)CD38(\u2212) leukemic stem cell frequency to predict outcome in acute myeloid leukemia. Leukemia. 2019;33:1102\u201312.","DOI":"10.1038\/s41375-018-0326-3"},{"key":"270_CR18","first-page":"226","volume":"14","author":"PM Kidd","year":"2009","unstructured":"Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Alter Med Rev. 2009;14:226\u201346.","journal-title":"Alter Med Rev"},{"key":"270_CR19","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1016\/j.sjbs.2017.03.014","volume":"25","author":"Y Yang","year":"2018","unstructured":"Yang Y, Liu K, Yang L, Zhang G. Bladder cancer cell viability inhibition and apoptosis induction by baicalein through targeting the expression of anti-apoptotic genes. Saudi J Biol Sci. 2018;25:1478\u201382.","journal-title":"Saudi J Biol Sci"},{"key":"270_CR20","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.bbrc.2006.10.064","volume":"351","author":"Y Hu","year":"2006","unstructured":"Hu Y, Yang Y, You QD, Liu W, Gu HY, Zhao L, et al. Oroxylin A induced apoptosis of human hepatocellular carcinoma cell line HepG2 was involved in its antitumor activity. Biochem Biophys Res Commun. 2006;351:521\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"270_CR21","doi-asserted-by":"publisher","first-page":"138","DOI":"10.2174\/156652408783769580","volume":"8","author":"MR Warr","year":"2008","unstructured":"Warr MR, Shore GC. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med. 2008;8:138\u201347.","journal-title":"Curr Mol Med"},{"key":"270_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.2174\/1566524016666160429121606","volume":"16","author":"J Zhan","year":"2016","unstructured":"Zhan J, He J, Zhou Y, Wu M, Liu Y, Shang F, et al. Crosstalk between the autophagy-lysosome pathway and the ubiquitin-proteasome pathway in retinal pigment epithelial cells. Curr Mol Med. 2016;16:487\u201395.","journal-title":"Curr Mol Med"},{"key":"270_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s13238-015-0143-7","volume":"6","author":"H Zhou","year":"2015","unstructured":"Zhou H, Xu R. Leukemia stem cells: the root of chronic myeloid leukemia. Protein Cell. 2015;6:403\u201312.","journal-title":"Protein Cell"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0270-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41401-019-0270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:02:09Z","timestamp":1684616529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-019-0270-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["270"],"URL":"https:\/\/doi.org\/10.1038\/s41401-019-0270-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}